XTLB
XTL Biopharmaceuticals Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.96
−0.01%Latest reported
- Last report date
- Dec 29, 2025
- EPS actual
- -$0.36
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Dec 29, 2025 | — | -$0.36 | — | — |
| Jun 30, 2025 | — | $0.10 | — | — |
| Dec 18, 2024 | — | -$0.04 | — | $162.0K |
| Sep 19, 2024 | — | -$0.07 | — | — |
| Dec 31, 2023 | — | -$0.21 | — | — |
| Aug 10, 2023 | — | -$0.28 | — | — |
| May 16, 2023 | — | -$0.68 | — | — |
| Jan 4, 2023 | — | -$0.55 | — | — |
| Nov 29, 2022 | — | -$0.60 | — | — |
| Aug 24, 2022 | — | -$0.40 | — | — |
| Jun 1, 2022 | — | $0.37 | — | — |
| Dec 31, 2021 | — | $1.45 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 29, 2026